Rankings
Pricing
Log In
Free Trial
US-listed companies
ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
PRQR
Market cap
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
iso4217:EUR
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Profit (loss)
-44
-37
-57
-47
-62
-65
Depreciation
-
-
-
2
-
3
Results related to associates
-
-
-
-
-0
-0
Gain on disposal of associate
-
-
-
-
1
-
Share-based compensation
4
5
9
8
6
3
Financial income and expense
-3
-1
0
-4
-3
-1
Results related to derecognition of financial liabilities
-
-
-
-
-
1
Results related to financial liabilities measured at fair value through profit or loss
-
-
-
-
2
-3
Income tax expenses
-
-
-
-
0
0
Changes in working capital
-0
-1
-2
5
-25
5
Cash used in operations
-
-
-
-
-
-65
Corporate income tax paid
0
0
0
0
0
0
Interest received
0
0
1
0
0
0
Interest paid
-
-
0
1
2
4
Net cash used in operating activities
-35
-28
-44
-47
-26
-69
Purchases of property, plant and equipment
0
0
1
1
0
1
Sales of property, plant and equipment
-
-
-
-
0
0
Net cash used in investing activities
-0
-0
-1
-1
-0
-1
Proceeds from issuing shares
26
84
49
-
108
14
Proceeds from exercise of options
0
1
0
1
2
0
Proceeds from borrowings
0
0
2
1
1
-
Repayment of convertible loans
-
-
-
-
-
43
Proceeds from convertible loans
1
1
1
14
27
-
Repayment of lease liability
-
-
1
1
1
2
Net cash (used in) / generated by financing activities
27
86
50
15
137
-31
Net increase/(decrease) in cash and cash equivalents
-8
58
6
-33
110
-100
Currency effect cash and cash equivalents
-3
-0
1
-3
1
7